Cytokines News and Research

Latest Cytokines News and Research

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.

28 Jul 2018

Nucleic acid nanoparticles found to have varying immune responses

An extensive experiment testing the immune effects of a broad group of lab-designed nucleic acid nanoparticles did not find a strong, uniform immune response, as had been predicted.

27 Jul 2018

Gene regulator associated with protein pileup in exfoliation glaucoma

In exfoliation glaucoma, a protein dandruff clogs the outflow pathway for the fluid in our eyes.

19 Jul 2018

High-fat diet and systemic inflammation contribute to progression of prostate cancer

Osaka University-led study shows how a high-fat diet and systemic inflammation contribute to prostate cancer progression

18 Jul 2018

Study identifies constellation of metabolites linked to ME/CFS

A study led by researchers at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health has identified a constellation of metabolites related to myalgic encephalomyelitis/chronic fatigue syndrome.

10 Jul 2018

Seeing the Unexpected: Regulatory T Cells and Basophils

Dr. Jagadeesh Bayry from INSERM discusses his recent research in the field of immunology, and how T regulatory cells activate, rather than suppress, basophils.

4 Jul 2018

Researchers discover gene that plays role in regulating body's immune response to infection

Australia's national science agency CSIRO has identified a new gene that plays a critical role in regulating the body's immune response to infection and disease.

2 Jul 2018

Scientists create microparticles that mimic human T cells

Researchers have developed synthetic microparticles with properties and behaviors that closely mimic human T cells.

27 Jun 2018

Researchers discover immune profile for effective cancer immunotherapy

In a new study published online June 25, 2018 in Nature Medicine, UC San Francisco researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response to immunotherapy drugs known as checkpoint inhibitors.

25 Jun 2018

Study: Oxidative stress can be used against tumors to treat cancer

Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

21 Jun 2018

Vitamin D and Diabetes: What You Need To Know

Dr. Cedric Garland discusses the results of a 12-year cohort study which showed that vitamin D3 can prevent type 1 diabetes in 80 percent of cases.

15 Jun 2018

Study finds link between inflammatory signals in heart muscle cells and atrial fibrillation

Interfering with inflammatory signals produced by heart muscle cells might someday provide novel therapeutic strategies for atrial fibrillation, according to an international team of researchers who have published their findings in the journal Circulation.

5 Jun 2018

New study shows how alcohol contributes to development of Alzheimer's disease

Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta -- the protein that forms globs of plaques in the brain and which contributes to neuronal damage and the cognitive impairment associated with Alzheimer's disease.

5 Jun 2018

Scientists identify 'hidden' driver that helps prime the anti-tumor immune response

Like exposing a crime boss whose authority has gone undetected, St. Jude Children's Research Hospital scientists have identified a hidden driver that influences production of the T cells that fight cancer and infections. The study appears today as an advance online publication in the journal Nature.

31 May 2018

Researchers uncover the cause of rheumatoid arthritis

A team of researchers have identified the cellular network involved in initiating and maintaining chronic inflammation in rheumatoid arthritis.

30 May 2018

Miniaturized device offers new way to gain insight into cell processes and communication

Like humans, cells of the same species each have a distinct "personality." When confronted with an external stimulus like a virus, they each secrete a different quantity of molecules and communicate with each other to a varying degree.

28 May 2018

Researchers reveal potent new mechanism of action for treatment of IBD

Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.

25 May 2018

Early-life obesity linked to children's lower perceptual reasoning and working memory scores

A new study by Brown University epidemiologists found that children on the threshold of obesity or overweight in the first two years of life had lower perceptual reasoning and working memory scores than lean children when tested at ages five and eight. The study also indicated that IQ scores may be lower for higher-weight children.

23 May 2018

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.

17 May 2018

Treatment for muscle wasting improved survival in pre-clinical cancer model

Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.

15 May 2018

Cytokines News and Research

Latest Cytokines News and Research

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Nucleic acid nanoparticles found to have varying immune responses

Gene regulator associated with protein pileup in exfoliation glaucoma

High-fat diet and systemic inflammation contribute to progression of prostate cancer

Study identifies constellation of metabolites linked to ME/CFS

Seeing the Unexpected: Regulatory T Cells and Basophils

Researchers discover gene that plays role in regulating body's immune response to infection

Scientists create microparticles that mimic human T cells

Researchers discover immune profile for effective cancer immunotherapy

Study: Oxidative stress can be used against tumors to treat cancer

Vitamin D and Diabetes: What You Need To Know

Study finds link between inflammatory signals in heart muscle cells and atrial fibrillation

New study shows how alcohol contributes to development of Alzheimer's disease

Scientists identify 'hidden' driver that helps prime the anti-tumor immune response

Researchers uncover the cause of rheumatoid arthritis

Miniaturized device offers new way to gain insight into cell processes and communication

Researchers reveal potent new mechanism of action for treatment of IBD

Early-life obesity linked to children's lower perceptual reasoning and working memory scores

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Treatment for muscle wasting improved survival in pre-clinical cancer model

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cytokines News and Research

Latest Cytokines News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in